National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 23929 [06-3879]
Download as PDF
Federal Register / Vol. 71, No. 79 / Tuesday, April 25, 2006 / Notices
Dated: April 14, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–3878 Filed 4–24–06; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
wwhite on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Loan Repayment Program.
Date: May 9, 2006.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference
Call).
Contact Person: Roberta Binder, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892, (301) 496–7966,
rbinder@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Loan Repayment Program,
Session 1.
Date: May 11, 2006.
Time: 1:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference
Call).
Contact Person: Roberta Binder, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B
VerDate Aug<31>2005
16:59 Apr 24, 2006
Jkt 208001
Rockledge Drive, MSC 7616, Bethesda, MD
20892, (301) 496–7966,
rbinder@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Specimen
Repository.
Date: May 12, 2006.
Time: 12:30 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference
Call).
Contact Person: Mary J. Homer, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892, (301) 496–7042,
mjhomer@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 14, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–3879 Filed 4–24–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Pregnancy.
Date: May 16, 2006.
Time: 1 p.m. to 3 p.m.
Agency: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Abubakar A. Shaikh, PhD,
DVM, Scientific Review Administrator,
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
23929
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
room 6168, MSC 7892, Bethsda, MD 20892,
(301) 435–1042, shaikha@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group, Modeling and Analysis of Biological
Systems Study Section.
Date: May 18–19, 2006.
Time: 8:30 a.m. to 5 p.m.
Agency: To review and evaluate grant
applications.
Place: Clarion Hotel Bethesda Park, 8400
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Malgorzata Klosek, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188,
MSC 7849, Bethesda, MD 20892, (301) 435–
2211, klosekm@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Nanotechnology and Nanoscience Special
Emphasis Panel.
Date: May 25–26, 2006.
Time: 8:30 a.m. to 5 p.m.
Agency: To review and evaluate grant
applications.
Place: Bethesda Park Hotel, 8400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sergei Ruvinov, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, (301) 435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group, Transplantation,
Tolerance, and Tumor Immunology.
Date: June 1–2, 2006.
Time: 8 a.m. to 12 p.m.
Agency: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
Contact Person: Cathleen L. Cooper, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4208,
MSC 7812, Bethsda, MD 20892, 301–435–
3566, cooperc@csr.nih.gov.
Name of Committee: Respiratory Sciences
Integrated Review Group, Lung Cellular,
Molecular, and Immunobiology Study
Section.
Date: June 1–2, 2006.
Time: 8 a.m. to 5 p.m.
Agency: To review and evaluate grant
applications.
Place: Wyndham City Center Hotel, 1143
New Hampshire Ave., NW., Washington, DC
20037.
Contact Person: George M. Barnas, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, 301–435–
0696, barnasg@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group, Cell Structure and
Function.
Date: June 1–2, 2006.
Time: 8 a.m. to 5:30 p.m.
Agency: To review and evaluate grant
applications.
E:\FR\FM\25APN1.SGM
25APN1
Agencies
[Federal Register Volume 71, Number 79 (Tuesday, April 25, 2006)]
[Notices]
[Page 23929]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-3879]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Loan Repayment Program.
Date: May 9, 2006.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6700, 6700B
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Roberta Binder, PhD, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892, (301) 496-7966, rbinder@niaid.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Loan Repayment Program, Session 1.
Date: May 11, 2006.
Time: 1:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6700, 6700B
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Roberta Binder, PhD, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892, (301) 496-7966, rbinder@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, NIAID Specimen Repository.
Date: May 12, 2006.
Time: 12:30 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Rockledge 6700, 6700B
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Mary J. Homer, PhD, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892, (301) 496-7042, mjhomer@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: April 14, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-3879 Filed 4-24-06; 8:45 am]
BILLING CODE 4140-01-M